1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform
Rent:
Rent this article for
USD
10.1063/1.4774309
/content/aip/journal/bmf/7/1/10.1063/1.4774309
http://aip.metastore.ingenta.com/content/aip/journal/bmf/7/1/10.1063/1.4774309
View: Figures

Figures

Image of FIG. 1.
FIG. 1.

Schematic representation of the microfluidic device for spheroid entrapment. (a) Layout of the device showing six serially located traps, indicated by the asterisks. (b) Mechanistic elaboration of serial spheroid entrapment. Dimensions of bypass and trapping sections are shown. Height of the microchannels = 500 μm. Black arrows indicate the bypass flow following spheroid entrapment and subsequent flow through the device. The inset in panel (b) demonstrates a trapped spheroid and its imaging with CTG. (c) Detailed illustration of a trapping section. L2 is the total length of the through channel, i.e.,sum of the lengths of trap and neck sections. Spheroid is depicted by the blue circle. (d) Phase-contrast image (4×objective) of two TOV112D spheroids trapped in a microfluidic device. (e) Image of a device containing 8 microchannel systems in a single glass slide, for parallelized analysis.

Image of FIG. 2.
FIG. 2.

Critical aspects of device fabrication. (a) Schematic representation of the device fabrication process by soft-lithography or PDMS-based rapid prototyping. (b) Representative image of the microfluidic devices. (c) Illustration detailing the necessity for a narrow outlet to reduce backflow. Backflow is due to the height difference between outlet and inlet liquid column and it is directly proportional to , where hi and h 0 are liquid column heights at the inlet and the outlet, respectively, and D 0 is the outlet diameter. Therefore, by reducing the diameter of outlet, it is possible to reduce the strength of backflow, although it cannot be completely eliminated in this system.

Image of FIG. 3.
FIG. 3.

Spheroid loading and live-dead cell imaging. (a) Phase contrast images of six TOV112D spheroids entrapped in a single microfluidic device. These spheroids were subjected to live-dead imaging by dual fluorescent staining technique. (b) Confocal image of a CTG-PI stained spheroid, as projected over 15 confocal z-sections across the spheroid height. (b-I): CTG (green fluorescent). (b-II) PI (red fluorescent). (b-III) CTG-PI merged channels. Note that PI monitored cell death is minimal and is evenly distributed spatially. Scale bar represents 120 μm.

Image of FIG. 4.
FIG. 4.

Distribution and temporal evolution of the mortality fraction. (a) Representative side view images of CTG-PI labeled TOV112D spheroids after 0, 6, and 24 h of incubation with 10× the TOV112D reference IC50 of carboplatin. I, III, and V illustrate merged confocal images while II, IV, and VI are corresponding pseudo-color images highlighting the distribution of mortality, in which red represents high mortality. Note that red intensity is more prominent with increased treatment time (compare 6 to 24 h). (b) Graphical representation of the imaging scheme. From top to bottom, 15 different cross-sectional images (termed image layers) were acquired for each spheroid. (c) Distribution of mortality fraction (number of dead cells/total number of cells in a single section) across 15 image layers comparing controls and spheroids treated with 10× the TOV112D monolayer IC50 of carboplatin for 6 or 24 h. Data are averaged over three independent experiments (total number of samples, n = 16) and shown as mean ± standard deviation.

Image of FIG. 5.
FIG. 5.

Effect of carboplatin and paclitaxel on TOV112D spheroids. The reference IC50 is based on drug responses in TOV112D monolayer cultures. (a) Merged CTG-PI confocal section (image layer #13) of spheroids subjected to carboplatin and paclitaxel at different concentrations. No image is provided for the 100 × IC50 paclitaxel treated spheroids, as under these conditions they lost their structural integrity and were fragmented during the vital dye staining. (b) Variation in the distribution of mortality fractions across all z-sections with varying carboplatin concentrations (1, 10, and 100 × IC50). (c)Variation in mortality distribution with changes in paclitaxel concentration (1 and 10 × IC50). Treatment time is 24 h for all samples. Each data point is averaged over three independent experiments (with total number of samples, n = 16) and shown as mean ± standard deviation.

Image of FIG. 6.
FIG. 6.

Radial distribution of the mortality fraction. (Left) Graphical delineation of the image analysis scheme to determine the radial distribution of the mortality fraction. (Middle, panels (a)–(c)) Averaged mortality distribution function of image layers 10-13. (Right) Representative sample images corresponding to the quantitative results. For each sample, distribution function has been normalized (dead cells within a radius range/the number total dead cells) so that integration of it over the whole radial domain remains one. The symbol * in (b) and (c) represents a point for which an increase or decrease in the mortality fraction is statistically significant (p < 0.01) with respect to controls. Each data point is averaged over three independent experiments (with total number of samples, n = 16) and shown as mean ± standard deviation. Note that treatment with carboplatin and paclitaxel showed a more prominent rise in mortality fraction closer to the spheroid center than near the edges.

Image of FIG. 7.
FIG. 7.

Effect of extracellular matrix (matrigel) and increased serum supplementation during spheroid formation on the chemotherapeutic response. (a) Distribution of the mortality fraction in image layers 8-15 of confocal z-sections and its dependence on matrigel and increased serum supplementation. (b) Representative merged CTG-PI confocal sections (image layer 13) of spheroids showing the variation of mortality with different culture conditions. In this panel, control corresponds to cells not exposed to carboplatin. (c) Response to carboplatin treatment was variable depending on the culture conditions, as accessed by the average morality fraction over image layers 8-15 of samples. Note that the simultaneous addition of matrigel and increased serum (20%) supplementation showed a statistically significant increase in chemoresistance, while neither had a significant effect alone. In addition, in the absence of drug, addition of matrigel and 20% serum appears tosignificantly diminish basal cell death within the spheroids (statistically significant in image layers 12 and 15). Each datapoint is averaged over three independent experiments (with total number of samples, n = 16) and shown as mean ±standard deviation.

Loading

Article metrics loading...

/content/aip/journal/bmf/7/1/10.1063/1.4774309
2013-01-10
2014-04-17
Loading

Full text loading...

This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform
http://aip.metastore.ingenta.com/content/aip/journal/bmf/7/1/10.1063/1.4774309
10.1063/1.4774309
SEARCH_EXPAND_ITEM